Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Nat Rev Cancer. 2019 Feb;19(2):97–109. doi: 10.1038/s41568-018-0095-3

Table 1:

Determinants of genomic evolution in cancer models.

Model type Major advantages for research Factors impacting genomic evolution
Genetically-engineered
mouse models
* De novo tumorigenesis in vivo
*  Interactions with the microenvironment and with other cell types
* Somatic evolution of the tumor as an integral part of tumorigenesis
* Germline evolution of the host throughout colony propagation
Patient-derived models New cancer cell lines *  Short time and few cell divisions from primary tumors to functional assays * Physical constraints (2D)
*   Variations in culture conditions (media, passaging practices, etc.)
* Continuous selection for rapidly proliferating cells
Established cancer cell lines * Widely accessible and easy to work with
* Ample genomic data available
* Numerous cell divisions
* Variations in culture conditions
*  Deficient mechanisms of genome maintenance inherited from tumor of origin
Xenografts * No growth on plastic
*  Functional investigation of human tumors in vivo
* Differences in physiology and metabolism between species
* Immune-deficient environment
* Site of transplantation
* Multiple cell divisions within each passage
Organoids * Complex cellular interactions
*  Culture conditions mimic in vivo conditions better than 2D culture
* 3D environment
* Matched normal controls
* Variations in culture conditions
*  Deficient mechanisms of genome maintenance inherited from tumor of origin
* Immune-deficient environment